News
Phase 2a trial of RAP-219 in refractory focal epilepsy fully enrolled and on track for topline results in September ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback